Products for Research Use Only
RegisterLogin

Plamotamab

CAT: 0804-HY-P99776-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99776-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Plamotamab (XmAb-13676) is a human bispecific antibody (bsAb) that binds CD3 and CD20. Plamotamab recruits cytotoxic T cells to kill CD20+ expressing tumor cells. Plamotamab induces a mild hematologic reaction (MR), and results in tumor regression in vivo[1][2].
CAS Number
2138442-31-4
Product Name Alternative
XmAb-13676
UNSPSC
12352203
Target
CD20; CD3
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/plamotamab.html
Purity
99.12
Solubility
10 mM in DMSO
Smiles
[plamotamab]
Molecular Weight
(124.88 kDa)
References & Citations
[1]Parrondo RD, et al. Plamotamab (XmAb®13676) for Ibrutinib- refractory CXCR4-mutated extramedullary Waldenström macroglobulinemia. Leuk Lymphoma. 2022 Mar;63 (3) :738-742. |[2]Luo Peter PZ, et al. Anti-CD3 antibodies and methods of use thereof. World Intellectual Property Organization, WO2022170740 A1. 2022-08-18.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
BA5854-1Plamotamab
GTR18337647-01Plamotamab Antibody
592117Plamotamab (CD3E, MS4A1)
HY257176-01Research Grade Plamotamab
KBI1559KRIBIOLISA™ Plamotamab ELISA
E55B1218Plamotamab (Reference antibody)
GTR18697925-01Plamotamab Human Monoclonal Antibody
10-952Plamotamab (CD3E/MS4A1) - Research Grade Biosimilar
YR1555-01Anti-Human CD3E & CD20 Recombinant Antibody (Plamotamab)
GTR18117100Plamotamab (CD3E/MS4A1) - Research Grade Biosimilar Antibody

Popular Products